Robert B. Gerber, MD
Pulmonary Disease Physician · Cleveland, OH
Robert B. Gerber, MD is a pulmonary disease physician with a practice address in Cleveland, Ohio, and NPI 1023059110, issued on Jun 9, 2006. Check the license (Ohio 35-077844, as entered in NPPES) on the State Medical Board of Ohio; the Medicare figures below come from public CMS files.
- Name
- Robert B. Gerber
- Credential
- MD
- Primary taxonomy
- Pulmonary Disease Physician 207RP1001X
- License number
- 35-077844 OH
Self-reported in NPPES; status is on the state search - Practice location
- 15805 Puritas Ave, Cleveland, OH 44135
- Phone
- (216) 267-5139
- Enumerated
- Jun 9, 2006
- Record last updated
- Aug 14, 2015 (not updated in 11 years: call before relying on the address or phone)
- Fax
- (216) 267-5133
- Medicaid ID
- 2516147 OH
- Medicare enrollment
- Enrolled (PECOS I20040923001050); accepts Medicare assignment
- Medical or professional school
- University Of Missouri, Kansas City, School Of Medicine, 1995
- Telehealth
- Offers telehealth (CMS)
- Entity
- Type 1 · individual
8 nearest pulmonary disease physician records → All 659 in Ohio → Look up another NPI →
Verify Robert B. Gerber in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersState Medical Board of Ohio
Search for license 35-077844Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
91% more Medicare Part D claims than the average pulmonary disease physician in 2024
2,723 Medicare Part D claims for 427 beneficiaries, against an average of 1,425 among the 11,596 providers of this specialty who prescribed in Part D. Brand-name drugs were 60% of claims.
Most prescribed
- Trelegy Ellipta534 claims
- Albuterol Sulfate Hfa486 claims
- Montelukast Sodium253 claims
- Prednisone164 claims
- Fluticasone-Salmeterol129 claims
- Breztri Aerosphere121 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Industry payments in 2024: $72.94
4 payments; by number, the most common kind was food and beverage; the largest payer was Actelion Pharmaceuticals US, Inc. The 8,806 providers of this specialty with any payment received $5,159.88 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through one group practice
- Summa Physicians LLCBarberton, OH
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Robert B. Gerber among 659 pulmonary disease physician records in Ohio
Robert B. Gerber, MD is one of 659 pulmonary disease physician records with a practice address in Ohio. 87% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2006, is newer than 12% of them.
- NPI issued2006 · 12% of these records are older, 56% newer
- In a Medicare fileYes · 87% of these records are
- In the CMS Doctors and Clinicians fileYes · 78% of these records are
- Graduated1995 · median 2005 among the 516 with a school on file
- Record last updated2015 · 48% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RP1001X and a Ohio practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Pulmonary Disease Physician providers in Ohio
There are 659 pulmonary disease physician records in Ohio.
All 659 in Ohio → Every provider in Cleveland → Pulmonary Disease Physician nationwide →
The 8 pulmonary disease physician records with the nearest ZIP codes
- Stephanie Clough, M.D.Independence, OH 441311144457227
- Anthony Dimarco, MDSolon, OH 441391730164740
- Gregory Hickey, D.O.Cleveland, OH 441391457391005
- Babu Eapen, MDMiddleburg Heights, OH 441301700823994
- Laxminarayana RaoMiddleburg Heights, OH 441301467492652
- Andre Smith, M.D.Parma, OH 441301801980636
- Timothy Taylor, DOCleveland, OH 441301851368914
- Linas Vaitkus, MDMiddleburg Heights, OH 441301992752752
Common questions
What is Robert B. Gerber, MD's NPI number?
Robert B. Gerber, MD's National Provider Identifier (NPI) is 1023059110, issued on Jun 9, 2006. An NPI identifies a provider in billing; it is not a license.
Where is Robert B. Gerber, MD located?
The NPPES record lists a practice address at 15805 Puritas Ave, Cleveland, OH, 44135. Phone: (216) 267-5139. Providers update this record themselves, so call before visiting.
How can I verify Robert B. Gerber, MD's license?
NPPES lists Ohio license number 35-077844, as entered by the provider. Search the State Medical Board of Ohio at https://elicense.ohio.gov/oh_verifylicense. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Robert B. Gerber, MD prescribe under Medicare Part D?
In 2024, Robert B. Gerber, MD had 2,723 Medicare Part D claims for 427 beneficiaries; the average among pulmonary disease physician prescribers was 1,425. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.